Status:
COMPLETED
Treatment of Post-traumatic Stress Disorder With High Doses of Escitalopram
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Stress Disorders, Post Traumatic
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The study evaluates the hypothesis that large doses of Escitalopram will reduce symptoms of chronic post-traumatic stress disorder (PTSD) in adult civilian survivors of traumatic events. Forty surviv...
Detailed Description
The study evaluates the hypothesis that large doses of Escitalopram will reduce symptoms of chronic post-traumatic stress disorder (PTSD) Forty adult survivors of carefully documented traumatic event...
Eligibility Criteria
Inclusion
- Adult survivors of traumatic events with chronic PTSD
Exclusion
- Individuals with past history of psychotic disorder, bipolar disorder, opiate or stimulants abuse.
- Individuals currently on anti-depressant therapy.
- Individuals with past history of a failure to respond to escitalopram
- Pregnant Women
- Medical condition excluding the treatment with escitalopram (e.g., renal or hepatic insufficiency). Current, life threatening medical illness. History or severe side effects with escitalopram (e.g., hyponatremia)
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00736021
Start Date
September 1 2008
End Date
March 1 2010
Last Update
March 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah University Hospital
Jerusalem, Israel, 91120